Rep. Stephanie N. Murphy

This resolution supports the designation of National Stalking Awareness Month. Additionally, it does the following: applauds the efforts of service providers, police, prosecutors, national and community organizations, campuses, and private sector supporters to promote awareness of stalking; encourages increased awareness of stalking and the availability of services for stalking victims; and urges national and community organizations, private businesses, and the media to promote awareness of the crime of stalking through National Stalking Awareness Month.

Maddy summaryHRES 437 is a symbolic House resolution designating June 4, 2021, as "National Gun Violence Awareness Day" and June 2021 as "National Gun Violence Awareness Month." It does not create new laws or policies but calls on the public to wear orange, increase awareness of gun violence, and focus on community safety efforts during summer months. The resolution references statistics on gun deaths and honors Hadiya Pendleton, a 15-year-old victim of gun violence, to highlight the issue. It has no direct legal effect on individuals or communities but aims to promote public discussion.

Deter PRC Support to the Russian War Effort Act The bill authorizes the President to impose sanctions on persons associated with China for financial, material, or technological support contributing materially to Russia's military action in Ukraine.  The sanctions include, for example, blocking transactions in U.S. property and prohibiting U.S. entry visas.

Multiple Firearm Sales Reporting Modernization Act of 2022 This bill expands reporting requirements with respect to sales or dispositions of multiple firearms. Currently, a federal firearms licensee (e.g., a gun dealer) must report multiple sales or dispositions of pistols or revolvers to the same person within five business days. This bill requires a federal firearms licensee to report multiple sales or dispositions of any firearms to the same person within five business days.

Stopping Harmful Image Exploitation and Limiting Distribution Act of 2022 or the SHIELD Act of 2022 This bill establishes a new criminal offense related to the distribution of intimate visual depictions. Specifically, it makes it a crime to knowingly distribute (or intentionally threaten to distribute) an intimate visual depiction of an individual (1) with knowledge of or reckless disregard for the individual's lack of consent and reasonable expectation of privacy, and (2) without a reasonable belief that distributing the depiction touches a matter of public concern. A violator is subject to criminal penalties—a fine, a prison term of up to two years for each individual victim depicted, or both.

Cuban Family Reunification Parole Act of 2022 This bill directs the Department of State to restart processing applications under the Cuban Family Reunification Parole Program. (The program, which was suspended in 2017, allows eligible U.S. citizens and lawful permanent residents to apply for parole for family members in Cuba, who can then enter the United States while waiting for immigrant visas.) The State Department must prioritize applications filed before this bill's enactment and ensure that the adjudication of such applications begin no later than six months after this bill's enactment date.

Russian Travel Sanctions for a Democratic Ukraine Act This bill imposes visa-blocking sanctions on certain citizens of Russia. Specifically, the President must impose such sanctions on citizens of Russia who are (1) Russian oligarchs, (2) employees of Russia's government, or (3) employees of companies that are owned by or receive funding from Russia's government. The President must also impose the sanctions on family members of such individuals. The President must coordinate with allies, including NATO member states, on the imposition of such sanctions. The President may waive the application of such sanctions in certain instances.

COPS on the Beat Grant Program Reauthorization and Parity Act of 2022 This bill reauthorizes through FY2031 and makes changes to the Community Oriented Policing Services grant program. Among the changes, the bill reduces the required matching contribution for certain rural communities during the first three years of a grant and eliminates the preference for agencies that exceed the matching requirements; allows grant funds to be used to increase wages of career law enforcement officers in states or localities that have a median household income of less than 70% of the national median household income and qualify for a reduced matching contribution; and provides statutory authority for the Office of Community Oriented Policing Services within the Department of Justice. Additionally, the bill requires the Government Accountability Office to report on whether law enforcement workforces are representative of the communities they serve, the percentage of law enforcement employees who live in the community they serve, the average pay of officers compared to the cost of living in the community they serve, and recommendations for improvements.

Reduced Costs and Continued Cures Act This bill establishes and alters several programs and requirements relating to the prices of prescription drugs. For example, the bill establishes and alters several requirements under Medicare and Medicaid, including requiring drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services for covered drugs under Medicare that cost $100 or more and for which the average manufacturer price increases faster than inflation, capping annual out-of-pocket spending under the Medicare prescription drug benefit, and increasing the maximum rebate amount under the Medicaid Drug Rebate Program. The bill also makes changes relating to market exclusivities and manufacturer price concessions for prescription drugs, including authorizing the Federal Trade Commission to initiate proceedings against parties to settlements of patent infringement claims that have anticompetitive effects with respect to drugs or biologics, limiting in certain instances the number of patents that the manufacturer of a biologic can assert in a lawsuit against a company seeking to sell a biosimilar version, and nullifying regulations relating to the treatment of certain Medicare prescription drug benefit rebates from drug manufacturers for purposes of federal anti-kickback laws.

Reduced Costs and Continued Cures Act of 2021 This bill establishes and alters several programs and requirements relating to the prices of prescription drugs. For example, the bill establishes and alters several requirements under Medicare and Medicaid, including requiring drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services for covered drugs under Medicare that cost $100 or more and for which the average manufacturer price increases faster than inflation, capping annual out-of-pocket spending under the Medicare prescription drug benefit, and increasing the maximum rebate amount under the Medicaid Drug Rebate Program. The bill also makes changes relating to market exclusivities and manufacturer price concessions for prescription drugs, including authorizing the Federal Trade Commission to initiate proceedings against parties to settlements of patent infringement claims that have anticompetitive effects with respect to drugs or biologics, limiting in certain instances the number of patents that the manufacturer of a biologic can assert in a lawsuit against a company seeking to sell a biosimilar version, and nullifying regulations relating to the treatment of certain Medicare prescription drug benefit rebates from drug manufacturers for purposes of federal anti-kickback laws.